Aug 23 (Reuters) - Newbury Pharmaceuticals AB
NEWBRY.ST :
* NEWBURY GAINS ACCESS TO THE NORDIC HOSPITAL MARKET WITH A
NEW
STRATEGIC PARTNERSHIP FOR PRESCRIPTION MEDICINE
* NEWBURY PHARMACEUTICALS AB - ENTERS NORDIC HOSPITAL MARKET
THROUGH A STRATEGIC PARTNERSHIP WITH A GLOBAL PHARMACEUTICAL
COMPANY
* PARTNERSHIP IS BASED ON AN AMBITION OF EXPANDING PORTFOLIO
OF
MEDICINES TO BECOME A KEY PLAYER IN HOSPITAL SEGMENT AND CAN
CONSIST OF BRANDED AND NON-BRANDED PRODUCTS.
* NEW STRATEGIC PARTNERSHIP IS EXPECTED TO CONTRIBUTE WITH
SALES
GROWTH AFTER REGULATORY APPROVALS HAVE BEEN OBTAINED DURING
2024/2025
* NEW STRATEGIC PARTNERSHIP IS BASED ON A DISTRIBUTION
AGREEMENT
WITH LIMITED FUTURE INVESTMENTS FOR NEWBURY
Source text for Eikon: ID:nMFN9SnqcT
Further company coverage: NEWBRY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))